ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

Clinical Trials Search


CurrentAll Trials


Trial Details

  • Trial statusCompleted
  • Study email contactHARMONY@imperial.ac.uk
  • Chief InvestigatorProfessor Neil Poulter
  • Project managerMary Cross
  • SponsorImperial College London
  • ISRCTN numbern/a
  • PhaseIV

Hellenic-Anglo Research into Morning Or Night antihypertensive drug deliverY Trial

Design and Objective

This is a prospective, randomised cross-over trial of anti-hypertensive medication dosing regimen in effective blood pressure control. This study will be performed at two investigational Centres in UK and Greece. Patients will be taking their ususal blood pressure medications.

Key inclusion criteria

- Aged 18-80 years - History of hypertension for at least 1 year - At least 3 months of constant antihypertensive medication (consisting of ≥ 1 antihypertensive drugs, each administered in one dose daily) - Relatively well controlled BP (150/90 mmHg and ≥ 115/65 mmHg on usual medication) at randomisation and prior 3 months

Study Disclaimer Statement